Filing Details
- Accession Number:
- 0001609351-18-000028
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-04-16 17:49:03
- Reporting Period:
- 2017-10-12
- Accepted Time:
- 2018-04-16 17:49:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1609351 | Spark Therapeutics Inc. | ONCE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1202294 | Elliot Sigal | C/O Spark Therapeutics, Inc. 3737 Market Street, Suite 1300 Philadelphia PA 19104 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-10-12 | 29 | $90.75 | 11,243 | No | 4 | P | Direct | |
| Common Stock | Disposition | 2017-11-28 | 29 | $72.43 | 11,214 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | S | Direct |
Footnotes
- Reflects transactions occurring in a brokerage account managed by an investment advisor who maintained discretionary authority over the account. The transactions were made by the investment advisor in contradiction of the Reporting Person's instructions and without the Reporting Person's approval.
Billionaire Hedge Funds
